Completed Genetics & Molecular Biology Cells, Biochemistry & Physiology

Molecular mechanism and regulatory function of protein coding gene transcriptional termination in mammalian genomes.

In plain English

AI plain-English summary

Every time a human cell reads a gene to make a protein, it must also know exactly where to stop reading—and that stop signal is frequently ignored or misread in cancer cells. This research tackles a fundamental gap in genomics: we can sequence entire human genomes, but we still do not understand how cells define where one gene ends and the next begins. The project will map, for the first time, which of the thousands of protein-coding genes use which molecular mechanism to terminate transcription. It will also explain why certain proteins thought to be universal terminators actually only work on a subset of genes, and how termination failures—common in cancer—produce fused, abnormal transcripts. This is fundamental science. It does not promise a new drug or diagnostic tomorrow. But understanding how transcription units are defined is a prerequisite for interpreting the thousands of cancer genomes now being sequenced. Without knowing where a gene normally stops, you cannot tell whether a fused transcript is a driver of disease or a harmless artifact. Past work on transcription termination has already revealed mechanisms that underpin RNA-based therapies; this project could provide the genomic context needed to make sense of the next wave of cancer genomics data.

View original technical description
The enormous facility with which mammalian genomes can be sequenced has outstripped our understanding of gene function in a genomic context. This disconnect between genomics and gene mechanism is especially evident in understanding how gene transcription units are defined. The major vision behind my proposal is to determine which genes terminate transcription by which mechanism and how this impacts on gene expression. To achieve this we will combine genomic analysis of nascent transcription with mechanistic studies that rely on molecular biological and biochemical analysis. Aims: 1) We will define in molecular detail the common mechanisms that mediate efficient transcriptional termination. 2) We will annotate which termination mechanisms act on which protein coding genes and how this may impact on their expression. 3) Many previously considered ubiquitous termination factors only affect a subset of protein coding genes. We aim to understand why this is the case and how it relates to gene regulation. 4) Transcriptional termination directly interconnects with all other stages of transcription. We will investigate the molecular basis of these interconnections. 5) Loss of termination causes read-through transcription (fused transcripts) a feature ofcancer cells. This suggests that cancer causes breakdown in normal transcription unitdefinition. We aim to better understand why termination is defective in cancer.

View the original record at the funder ↗

Researchers

Nicholas Proudfoot (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

CTD phosphorylation and transcription termination
Epigenetic control of transcription termination
Mechanisms of transcription termination
Control of RNA biogenesis by promoter-proximal transcription termination
Dissection of the mammalian transcription termination mechanism by CRISPRi technology.

Original classification

Investigator Award in Science

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.